Interferon beta in multiple sclerosis. Reducing frequency and severity of relapses will be of great clinical benefit
Burnfield, A.
Bmj 314(7080): 600
1997
ISSN/ISBN: 0959-8138 PMID: 9055727 Document Number: 470291
Document emailed within 1 workday
Related Documents
Cardy, P. 1997: Interferon beta in multiple sclerosis. Relapses deserve treatment Bmj 314(7080): 602Lebrun, C. 2001: Beta-interferon clinical trials using MRI in patients with multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 1): 761-767
De Haan, R.J.; Polman, C.H. 1996: Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis Nederlands Tijdschrift Voor Geneeskunde 140(44): 2168-2171
Pokryszko-Dragan, A.; Bilińska, M.łg.; Gruszka, E.; Dubik-Jezierzańska, M. 2005: Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(113): 654-658
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Wilson, B.A. 1995: Interferon beta for treatment of multiple sclerosis Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 4(2): 151-153
Bencsik, K.; Rajda, C.; Klivényi, P.; Járdánházy, T.; Török, M.; Vécsei, L. 1999: Treatment of relapsing-remitting multiple sclerosis with interferon beta type 1-b Orvosi Hetilap 140(14): 763-766
Khabirov, F.A.; Babicheva, N.N.; Khaĭbullin, T.I.; Aver'ianova, L.A.; Granatov, E.V.; Akhmedova, G.M. 2012: Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(9 Part 2): 113-122
Demina, T.L.; Khachanova, N.V.; Davydovskaia, M.V. 2005: Use of beta-interferon in the treatment of multiple sclerosis: high-rate injectable dose therapy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 105(5): 76-79
Bartholomé, E.J.; Willems, F.; Crusiaux, A.; Thielemans, K.; Schandené, L.; Goldman, M. 1999: Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis Acta Neurologica Belgica 99(1): 44-52
Rubio-Terrés, C.; Domínguez-Gil Hurlé, A. 2005: Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain Revista de Neurologia 40(12): 705-710
Nagasawa, H.; Takashima, S.; Hirade, S.; Inoue, H. 1997: A case of multiple sclerosis with relapses during the third trimester of pregnancy Rinsho Shinkeigaku 37(10): 933-936
Svenningsson, A.; Andersson, M.; Olsson, T. 1998: Treatment of multiple sclerosis--1. New drugs may be effective but there still are frequent relapses Lakartidningen 95(49): 5623-7 5630
Danilova, L.V.; Popova, E.V.; Kulakova, O.G.; Tsareva, E.I.; Favorov, A.V.; Favorova, O.O.; Boĭko, A.N. 2014: The activation of the type i interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(2 Part 2): 72-77
Richards, R.; Burls, A.; Payne, N. 2000: Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit Bmj 320(7247): 1475; Author Reply 1475-6
Fischbach, R.; Harrer, G.; Wagner, F. 1972: Changes in flicker-fusion frequency in patients with multiple sclerosis Die Medizinische Welt 23(4): 120-122
Vervliet, G.; Schandené, L. 1985: In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosis Clinical and Experimental Immunology 61(3): 556-561
Pérez Castrillón, J.L.; Cano-del Pozo, M.; Sanz-Izquierdo, S.; Velayos-Jiménez, J.; Dib-Wobakin, W. 2003: Bone mineral density in patients with multiple sclerosis: the effects of interferon Revista de Neurologia 36(10): 901-903
Palao-Duarte, S.; Corral-Corral, I.; Zarza, B.; Costa-Frossard, L. 2005: Ulcerative colitis in a female patient with multiple sclerosis receiving treatment with interferon Revista de Neurologia 41(5): 319-320
Huber, M. 1988: Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results Der Nervenarzt 59(9): 514-520